Maddie Gehrich is the Investor Relations Associate at EcoR1 Capital. Prior to joining the firm and Partner Relations team in 2023, she spent two years at Stern Investor Relations where she consulted both public and private biotechnology and pharmaceutical companies of various target disease indications regarding IR strategy and investor communications. She began her professional career working with hospital systems to identify and recover revenue for underpaid medical services at Cloudmed (formerly Triage Consulting Group). Ms. Gehrich holds a Bachelor of Science in Human Biology and Society with a concentration in Bioethics and Public Science Policy from the University of California, Los Angeles.